Skip to content
Screener

Illumina ILMN Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Revvity logo
RevvityRVTY
$5.44M+107%
Azenta logo
AzentaAZTA
$1.22M-24.0%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$255K
Personalis, Inc. logo
Personalis, Inc.PSNL
$20.95M+17.8%
Guardant Health logo
Guardant HealthGH
$3.65M+375%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$1.79M+132%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Gross profit$770.0M+10.8%
Operating income$245.0M+14.5%
Net income$207.0M-11.9%
EPS (diluted)$1.35-9.4%

Balance sheet

See full
Cash & equivalents$1.0B+11.3%
Total debt$1.9B-7.3%
Total equity$2.8B+25.7%
Total assets$6.7B+9.2%

Cash flow

See full
Operating cash flow$201.0M-14.1%
CapEx$39.0M+30.0%
Free cash flow$162.0M-20.6%

Valuation

See full
Market cap$30.18B+102%
Enterprise value$31.09B+92.9%
P/E36.6×+24.7×
P/S6.7×+3.2×

Profitability

See full
Gross margin66.4%-0.2pp
Operating margin19.6%
Net margin18.4%-11.0pp
FCF margin20.7%-3.3pp

Returns & leverage

See full
Return on equity32.4%-35.7pp
Debt / equity0.7×-0.2×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The source filing: Illumina’s 10-Q, filed May 4, 2026.

Filed
May 3, 2026, 8:00 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001110803-26-000092
Line itemThree Months Ended / March 29,2026Three Months Ended / March 30,2025
Cash flows from financing activities:
Common stock repurchases(242)(200)
Taxes paid related to net share settlement of equity awards(33)(22)
Proceeds from issuance of common stock2427
Net cash used in financing activities(251)(195)
Effect of exchange rate changes on cash and cash equivalents(1)4
Net decrease in cash and cash equivalents(329)(14)
Cash and cash equivalents at beginning of period1,4181,127

Cover / Front Matter

FAQ

What is Illumina's stock issuance proceeds?
Illumina (ILMN) reported stock issuance proceeds of $24M in Q1 2026.
How has Illumina's stock issuance proceeds changed year-over-year?
Illumina's stock issuance proceeds decreased by 11.1% year-over-year, from $27M to $24M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Ask your AI about Illumina's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude